Insulin degludec is a new ultra-long-acting insulin analogue
Achieving optimal glycemic control is an important aspect of preventing and slowing the progression of diabetes-associated complications, and reducing the cost of their treatment. Long-acting insulin analogues, glargine and detemir, provide better metabolic control with reduced risk of hypoglycaemia...
Saved in:
Main Authors: | , |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/6e417b1bfcf04a568b284fe7ce6e9f5f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|